US FDA backlog holding up revamp of inactive ingredients database
The process of sorting out problems with the US FDA’s controversial Inactive Ingredients Database (IID) is shaping up to be a huge task, particularly as the agency is working through a backlog of missing updates extending back several years.
By Phil Taylor, 07-Mar-2016
By Phil Taylor, 07-Mar-2016
http://www.in-pharmatechnologist.com/Ingredients/US-FDA-backlog-holding-up-revamp-of-inactive-ingredients-database
http://www.in-pharmatechnologist.com/Ingredients/US-FDA-backlog-holding-up-revamp-of-inactive-ingredients-database